Literature DB >> 9774441

Crystal structure of the catalytic domain of protein-tyrosine phosphatase SHP-1.

J Yang1, X Liang, T Niu, W Meng, Z Zhao, G W Zhou.   

Abstract

The crystal structures of the protein-tyrosine phosphatase SHP-1 catalytic domain and the complex it forms with the substrate analogue tungstate have been determined and refined to crystallographic R values of 0.209 at 2.5 A resolution and 0.207 at 2.8 A resolution, respectively. Despite low sequence similarity, the catalytic domain of SHP-1 shows high similarity in secondary and tertiary structures with other protein-tyrosine phosphatases (PTPs). In contrast to the conformational changes observed in the crystal structures of PTP1B and Yersinia PTP, the WPD loop (Trp419-Pro428) in the catalytic domain of SHP-1 moves away from the substrate binding pocket after binding the tungstate ion. Sequence alignment and structural analysis suggest that the residues in the WPD loop, especially the amino acid following Asp421, are critical for the movement of WPD loop on binding substrates and the specific activity of protein-tyrosine phosphatases. Our mutagenesis and kinetic measurements have supported this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774441     DOI: 10.1074/jbc.273.43.28199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Structural and evolutionary relationships among protein tyrosine phosphatase domains.

Authors:  J N Andersen; O H Mortensen; G H Peters; P G Drake; L F Iversen; O H Olsen; P G Jansen; H S Andersen; N K Tonks; N P Møller
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

2.  Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells.

Authors:  Young H Lee; Ognoon Mungunsukh; Rebecca L Tutino; Ana P Marquez; Regina M Day
Journal:  J Cell Sci       Date:  2010-04-20       Impact factor: 5.285

Review 3.  Molecular underpinning of B-cell anergy.

Authors:  Yuval Yarkoni; Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

Review 4.  Targeting protein tyrosine phosphatases for anticancer drug discovery.

Authors:  Latanya M Scott; Harshani R Lawrence; Saïd M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

Review 5.  Overview of protein structural and functional folds.

Authors:  Peter D Sun; Christine E Foster; Jeffrey C Boyington
Journal:  Curr Protoc Protein Sci       Date:  2004-05

6.  Rational design of allosteric-inhibition sites in classical protein tyrosine phosphatases.

Authors:  Cynthia M Chio; Xiaoling Yu; Anthony C Bishop
Journal:  Bioorg Med Chem       Date:  2015-03-17       Impact factor: 3.641

Review 7.  Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy.

Authors:  Man-Hsin Hung; Wei-Tien Tai; Chung-Wai Shiau; Kuen-Feng Chen
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

8.  Residue 182 influences the second step of protein-tyrosine phosphatase-mediated catalysis.

Authors:  Anja K Pedersen; Xiao-Ling Guo; Karin B Møller; Günther H Peters; Henrik S Andersen; Jette S Kastrup; Steen B Mortensen; Lars F Iversen; Zhong-Yin Zhang; Niels Peter H Møller
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

9.  Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds.

Authors:  Harshani R Lawrence; Roberta Pireddu; Liwei Chen; Yunting Luo; Shen-Shu Sung; Ann Marie Szymanski; M L Richard Yip; Wayne C Guida; Saïd M Sebti; Jie Wu; Nicholas J Lawrence
Journal:  J Med Chem       Date:  2008-08-05       Impact factor: 7.446

10.  Knowledge-based characterization of similarity relationships in the human protein-tyrosine phosphatase family for rational inhibitor design.

Authors:  Dusica Vidović; Stephan C Schürer
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.